1. Home
  2. TNET vs CLDX Comparison

TNET vs CLDX Comparison

Compare TNET & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$66.72

Market Cap

3.2B

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$41.36

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
CLDX
Founded
1988
N/A
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
TNET
CLDX
Price
$66.72
$41.36
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$65.80
$46.60
AVG Volume (30 Days)
385.0K
942.8K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
2.57%
N/A
EPS Growth
N/A
N/A
EPS
3.05
N/A
Revenue
$5,010,000,000.00
$12,743,000.00
Revenue This Year
N/A
$111.39
Revenue Next Year
$3.30
$235.85
P/E Ratio
$22.42
N/A
Revenue Growth
N/A
87.78
52 Week Low
$33.67
$19.72
52 Week High
$73.08
$41.15

Technical Indicators

Market Signals
Indicator
TNET
CLDX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TNET
CLDX

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: